AJANTPHARM.NS

AJANTPHARM

₹ 0

0.00%

Live Market Data

Market Cap₹ 0 Cr.

Current Price₹ 0

High / Low₹0 / 0

Stock P/E0.0

Book Value₹0.0

Dividend Yield0.00 %

ROCE0.0 %

ROE0.0 %

About Company

Unavailable

Price Chart

Loading Chart...

Price50 DMA200 DMA

Technical Analysis

Technical Outlook

Short TermBearish

Mid TermBullish

Long TermNeutral

Resistance₹3119.5

Support₹0

Valuation Check

Fair Value Assessment

Fair Value

Research Reports

No recent reports available.

Peer Comparison

Related Sector

Company	Price	P/E	M.Cap (Cr)	ROE %
TORRENT PHARMACEUTICALS L TORNTPHARM	₹4,390	65.36	1,48,578	-
ALEMBIC PHARMA LTD APLLTD	₹677.95	21.14	13,358	-
ALKEM LABORATORIES LTD. ALKEM	₹5,355.5	27.03	64,033	-
IPCA LABORATORIES LTD IPCALAB	₹1,561.3	43.48	39,755	-
NATCO PHARMA LTD. NATCOPHARM	₹955.85	10.99	17,130	-

Quarterly Results

Particulars	Dec 25	Jun 25	Dec 24	Jan 70	Jan 70
Total Revenue (Cr)	1,374.84	1,302.65	1,146.13	1,109.82	1,186.64
Net Income (Cr)	273.77	255.34	232.88	225.26	216.48
EPS (₹)	21.91	20.44	18.6	0	17.27

Annual Profit & Loss

Particulars	2025	2024	2023	2022
Total Revenue (Cr)	4,587.51	4,161.59	3,707.52	3,284.13
Operating Exp (Cr)	2,331.9	2,000.63	1,911.03	1,585.53
Net Income (Cr)	920.39	816.17	587.98	712.68
EPS (₹)	73.56	64.82	45.89	54.97

Balance Sheet

Particulars	Dec 25	Jun 25	Dec 24	Jan 70	Jan 70
Total Assets (Cr)	-	-	-	5,014.95	4,790.5
Total Liabilities (Cr)	-	-	-	1,224.66	1,113.55
Total Equity (Cr)	-	-	-	3,790.29	3,676.95

Key Ratios Fundamentals

Valuation

P/E Ratio (TTM)

35.46

Forward P/E

28.97

PEG Ratio

Price / Book

8.34

EV / EBITDA

25.58

Profitability

ROE

ROA

Profit Margin

19.50%

Operating Margin

24.64%

Liquidity & Debt

Current Ratio

Quick Ratio

Debt / Equity

5.70

Total Cash (Cr)

940.08

Price Statistics

Beta

0.18

52W High

3228.00

52W Low

2327.30

Dividend Yield

1.94%

Pattern Unavailable

Detailed shareholding breakdown is not currently provided by the exchange.